Intranasal delivery of cell-penetrating anti-NF-κB peptides (Tat-NBD) alleviates infection-sensitized hypoxic-ischemic brain injury.

Intranasal delivery of cell-penetrating anti-NF-κB peptides (Tat-NBD) alleviates infection-sensitized hypoxic-ischemic brain injury.
复制标题

细胞渗透抗NF-κB肽(TAT-NBD)的鼻内递送减轻感染敏感的低氧缺血性脑损伤。

DOI:
10.1016/j.expneurol.2013.01.015
复制
发表时间:
2013-09
影响因子:
5.3
通讯作者:
Kuan, Chia-Yi
Kuan, Chia-Yi
中科院分区:
医学2区
文献类型:
--
作者:
Yang, Dianer;Sun, Yu-Yo;Lin, Xiaoyi;Baumann, Jessica M.;Dunn, R. Scott;Lindquist, Diana M.;Kuan, Chia-Yi

文献摘要

参考文献

相似文献

Perinatal infection aggravates neonatal hypoxic-ischemic (HI) brain injury and may interfere with therapeutic hypothermia. While the NF-κB signaling pathway has been implicated in microglia activation in infection-sensitized HI, the current therapeutic strategies rely on systemic intervention, which could impair neonatal immunity and increase the risk of severe infection. To devise a brain-targeted anti-NF-κB strategy, we examined the effects of intranasal delivery of tat-NBD peptides in two animal models of neonatal infection-sensitized HI. Kinetics experiments showed that tat-NBD peptides entered the olfactory bulbs rapidly (10-30 min) and peaked in the cerebral cortex around 60 min after intranasal application in P7 rats. Further, intranasal delivery of 1.4 mg/kg tat-NBD, which is only 7% of the intravenous dose in past studies, markedly attenuated NF-κB signaling, microglia activation, and brain damage triggered by HI with 4 or 72 h pre-exposure to the bacterial endotoxin lipopolysaccharide (LPS). In contrast, intranasal delivery of mutant tat-NBD peptides or systemic application of minocycline failed to block LPS-sensitized HI injury. Yet, intranasal delivery of up to 5.6 mg/kg tat-NBD peptides immediately after pure-HI insult showed litter protection, likely due to its rapid clearance from the brain and inability to inhibit parenchymal plasminogen activators. Together, these results suggest a novel therapy of infection-sensitized HI brain injury in newborns.
DOI: 10.1016/j.jneumeth.2011.09.029
发表时间: 2012-01-15
影响因子: 3
作者:
Sun, Yu-Yo;Yang, Dianer;Kuan, Chia-Yi
通讯作者: Kuan, Chia-Yi
DOI: 10.1161/strokeaha.108.516401
发表时间: 2008-09-01
期刊: STROKE
影响因子: 8.3
作者:
Nijboer, Cora H.;Heijnen, Cobi J.;Kavelaars, Annemieke
通讯作者: Kavelaars, Annemieke
DOI: 10.3109/10611860903318134
发表时间: 2010-04
影响因子: 4.5
作者:
Alcalá-Barraza SR;Lee MS;Hanson LR;McDonald AA;Frey WH 2nd;McLoon LK
通讯作者: McLoon LK
DOI: 10.1002/glia.21091
发表时间: 2011-02
期刊: GLIA
影响因子: 6.2
作者:
Choi, Judy;Ifuku, Masataka;Noda, Mami;Guilarte, Tomas R.
通讯作者: Guilarte, Tomas R.
DOI: 10.1523/jneurosci.0698-11.2011
发表时间: 2011-06-15
期刊: The Journal of neuroscience : the official journal of the Society for Neuroscience
影响因子: --
作者:
Akpan N;Serrano-Saiz E;Zacharia BE;Otten ML;Ducruet AF;Snipas SJ;Liu W;Velloza J;Cohen G;Sosunov SA;Frey WH 2nd;Salvesen GS;Connolly ES Jr;Troy CM
通讯作者: Troy CM